Innoviva (INVA) News Today $19.57 -0.31 (-1.56%) Closing price 04:00 PM EasternExtended Trading$19.57 0.00 (-0.03%) As of 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period What is HC Wainwright's Estimate for Innoviva Q2 Earnings?July 18 at 2:15 AM | americanbankingnews.comInnoviva (NASDAQ:INVA) Earns Buy Rating from Analysts at HC WainwrightJuly 17 at 4:15 AM | americanbankingnews.comQ2 Earnings Estimate for Innoviva Issued By HC WainwrightJuly 16 at 6:25 AM | marketbeat.comHC Wainwright & Co. Initiates Coverage of Innoviva (INVA) with Buy RecommendationJuly 15 at 12:04 PM | msn.comInnoviva (NASDAQ:INVA) Upgraded to "Strong-Buy" at HC WainwrightJuly 15 at 7:34 AM | marketbeat.comCantor Fitzgerald Forecasts Innoviva FY2026 EarningsJuly 15 at 2:51 AM | americanbankingnews.comInnoviva (NASDAQ:INVA) Now Covered by Cantor FitzgeraldJuly 14, 2025 | americanbankingnews.comCantor Fitzgerald Predicts Innoviva FY2026 EarningsJuly 14, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Innoviva (INVA) with Overweight RecommendationJuly 12, 2025 | msn.comInnoviva (NASDAQ:INVA) Coverage Initiated at Cantor FitzgeraldJuly 11, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Allspring Global Investments Holdings LLCJuly 9, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) shareholders are still up 45% over 5 years despite pulling back 4.1% in the past weekJuly 1, 2025 | uk.finance.yahoo.comFirst Week of August 15th Options Trading For Innoviva (INVA)June 24, 2025 | nasdaq.comSG Americas Securities LLC Makes New $737,000 Investment in Innoviva, Inc. (NASDAQ:INVA)June 21, 2025 | marketbeat.comCWA Asset Management Group LLC Increases Stake in Innoviva, Inc. (NASDAQ:INVA)June 20, 2025 | marketbeat.comExchange Traded Concepts LLC Grows Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)June 17, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Hits New 12-Month High - Should You Buy?June 16, 2025 | marketbeat.comPromising Market Opportunity for Theravance Biopharma: Buy Rating on Ampreloxetine’s Potential in MSA TreatmentJune 16, 2025 | tipranks.comInnoviva Specialty's gonorrhea antibiotic to undergo FDA reviewJune 10, 2025 | msn.comInnoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in AdultsJune 10, 2025 | businesswire.comInnoviva: A Riddle Wrapped In A Mystery Inside An EnigmaJune 8, 2025 | seekingalpha.comGAMMA Investing LLC Acquires 77,145 Shares of Innoviva, Inc. (NASDAQ:INVA)June 7, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Sets New 1-Year High - Time to Buy?June 6, 2025 | marketbeat.comTheravance Biopharma’s Hold Rating: Balancing Cash Influx with Long-term Growth UncertaintyJune 4, 2025 | tipranks.comTheravance Biopharma Sells Trelegy Royalty Interest to GSKJune 2, 2025 | tipranks.comNuveen Asset Management LLC Has $5.32 Million Position in Innoviva, Inc. (NASDAQ:INVA)June 1, 2025 | marketbeat.comTwo Sigma Investments LP Has $4.56 Million Stock Position in Innoviva, Inc. (NASDAQ:INVA)May 29, 2025 | marketbeat.comJefferies Financial Group Inc. Has $5.14 Million Stake in Innoviva, Inc. (NASDAQ:INVA)May 28, 2025 | marketbeat.comTwo Sigma Advisers LP Lowers Stock Position in Innoviva, Inc. (NASDAQ:INVA)May 28, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLCMay 28, 2025 | marketbeat.comBank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA)May 23, 2025 | marketbeat.comMan Group plc Acquires 81,891 Shares of Innoviva, Inc. (NASDAQ:INVA)May 21, 2025 | marketbeat.comTheravance Biopharma Holds 2025 Annual General MeetingMay 20, 2025 | tipranks.comZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial InfectionsMay 20, 2025 | businesswire.comBalyasny Asset Management L.P. Takes $277,000 Position in Innoviva, Inc. (NASDAQ:INVA)May 20, 2025 | marketbeat.comBasilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United StatesMay 20, 2025 | globenewswire.comSystematic Financial Management LP Has $35.20 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)May 19, 2025 | marketbeat.comComerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA)May 19, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust CorpMay 19, 2025 | marketbeat.com21,999 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Occudo Quantitative Strategies LPMay 18, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by D. E. Shaw & Co. Inc.May 16, 2025 | marketbeat.comJefferies Financial Group Inc. Has $5.14 Million Position in Innoviva, Inc. (NASDAQ:INVA)May 15, 2025 | marketbeat.com16,198 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Brevan Howard Capital Management LPMay 14, 2025 | marketbeat.comTheravance Biopharma to Participate in an Upcoming Investor Conference | TBPH Stock NewsMay 13, 2025 | gurufocus.comJane Street Group LLC Purchases 194,270 Shares of Innoviva, Inc. (NASDAQ:INVA)May 12, 2025 | marketbeat.comBridgeway Capital Management LLC Has $3.23 Million Stake in Innoviva, Inc. (NASDAQ:INVA)May 11, 2025 | marketbeat.comTheravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress | ...May 9, 2025 | gurufocus.comTheravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...May 9, 2025 | gurufocus.comInnoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are SellingMay 8, 2025 | msn.comSchonfeld Strategic Advisors LLC Purchases 14,957 Shares of Innoviva, Inc. (NASDAQ:INVA)May 8, 2025 | marketbeat.com Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼0.770.96▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼163▲INVA Articles Average Week Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Dynavax Technologies News MannKind News Novavax News OPKO Health News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our Partners[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredWhen your faith is put to the test, what will you do?Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
